XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash provided by (used for) operating activities    
Cash provided by (used for) operating activities $ 192 $ 642
Investing activities:    
Purchases of property, plant and equipment (168) (154)
Proceeds from sale of property, plant and equipment 4 2
Payments for acquisitions of businesses, net of cash acquired (3) (763)
Proceeds from royalty rights 45 0
Payments for investments and acquisitions of certain technologies (29) (115)
Proceeds from divestiture 15 0
Cash provided by (used for) investing activities (135) (1,030)
Financing activities:    
Payment of contingent consideration and royalty rights established in purchase accounting (90) (64)
Payments on short-term borrowings (2,700) (1,000)
Proceeds from short-term borrowings, net of debt issuance costs 2,245 0
Net increase (decrease) in commercial paper (714) 675
Payments on borrowings from credit facilities (1,919) 0
Proceeds from borrowings on credit facilities 1,916 0
Payments on long-term borrowings and debt extinguishment costs (1,000) (1,472)
Proceeds from long-term borrowings, net of debt issuance costs 1,683 4,243
Net proceeds from issuance of preferred stock in connection with public offering 975 0
Net proceeds from issuance of common stock in connection with public offering 975 0
Cash used to net share settle employee equity awards (57) (61)
Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans 48 63
Cash provided by (used for) financing activities 1,361 2,383
Effect of foreign exchange rates on cash (9) 0
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents 1,409 1,994
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 607 829
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period 2,016 2,823
Supplemental Information    
Stock-based compensation expense 88 74
Fair value of contingent consideration recorded in purchase accounting 0 131
Non-cash impact of transferred royalty rights $ (45) $ 0